NRS-2002营养评估与肝细胞癌患者肝切除术后无复发生存时间及总生存时间的关系

田甜; 张姮; 姜挺

doi:10.3969/j.issn.1001-5256.2019.09.017

NRS-2002营养评估与肝细胞癌患者肝切除术后无复发生存时间及总生存时间的关系

DOI: 10.3969/j.issn.1001-5256.2019.09.017

华中科技大学同济医学院附属武汉中心医院消化内科

基金项目:

国家自然科学基金(2016CFB591)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1472
- HTML全文浏览量: 46
- PDF下载量: 248
- 被引次数: 13
出版历程
- 收稿日期: 2019-04-11
- 出版日期: 2019-09-20

Association of Nutritional Risk Assessment 2002 score with recurrence-free survival time and overall survival time in patients undergoing hepatectomy

Department of Gastroenterology, Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology

Research funding:

摘要

摘要: 目的探讨营养风险评估表（NRS-2002）与肝细胞癌（HCC）肝切除术患者无复发生存时间及总生存时间之间的关系。方法选取2013年1月-2017年1月在武汉中心医院首次行肝切除术治疗的HCC患者。采用NRS-2002评分评估HCC患者术前的营养状态。所有患者均随访,根据随访结果记录无复发生存时间及总生存时间。计数资料2组间比较采用χ2检验。采用Kaplan-Meier检验对无复发生存时间及总体生存时间进行分析。复发及死亡的独立危险因素采用多因素Cox比例风险模型分析。结果根据NRS-2002评分筛查结果显示,230例HCC患者术前存在营养风险72例,营养正常158例,营养风险发生率31. 3%。随访时间7～80个月,平均随访（46. 14±10. 52）个月。所有患者中,复发91例（39. 6%）,死亡43例（18. 7%）,1年复发率10%（23/230）、3年复发率28. 3%（65/230）、5年复发率35. 2%（81/230）; 1年病死率1. 7%（4/230）、3年病死率12. 2%（28/230）、5年病死率16. 1%（37/230）。其中营养风险患者复发37例（51...
- 癌,肝细胞 /
- 营养风险评估表 /
- 肝切除术 /
- 预后
Abstract: Objective To investigate the association of Nutritional Risk Assessment 2002 ( NRS-2002) score with recurrence-free survival time and overall survival time in hepatocellular carcinoma ( HCC) patients undergoing hepatectomy. Methods The HCC patients who underwent hepatectomy for the first time in Wuhan Central Hospital from January 2013 to January 2017 were enrolled. The NRS-2002 score was used to evaluate nutritional status before surgery. All patients were followed up, and recurrence-free survival time and overall survival time were recorded. The chi-square test was used for comparison of categorical data between groups. The Kaplan-Meier method was used to analyze recurrence-free survival time and overall survival time. The multivariate Cox proportional hazard model was used to investigate the independent risk factors for recurrence and death. Results According to the NRS-2002 score, 72 HCC patients had nutritional risk and 158 patients had normal nutrition before surgery, with an incidence rate of nutritional risk of 31. 3%. The patients were followed up for7-80 months ( mean 46. 14 ± 10. 52 months) . Of all patients, 91 ( 39. 6%) experienced recurrence and 43 ( 18. 7%) died. The 1-, 3-, and 5-year recurrence rates were 10% ( 23/230) , 28. 3% ( 65/230) , and 35. 2% ( 81/230) , respectively, and the 1-, 3-, and5-year mortality rates were 1. 7% ( 4/230) , 12. 2% ( 28/230) , and 16. 1% ( 37/230) , respectively. Among the 72 patients with nutritional risk, 37 ( 51. 4%) experienced recurrence and 20 ( 27. 8%) died, and among the 158 patients with normal nutrition, 54 ( 34. 2%) experienced recurrence and 23 ( 14. 6%) died. The patients with normal nutrition had significantly longer overall survival time and recurrence-free survival time than those with nutritional risk ( P < 0. 05) . The number of tumors ( hazard ratio [HR]= 1. 682, 95% confidence interval [CI]: 1. 161-2. 438) , vascular invasion ( HR = 1. 996, 95% CI: 1. 372-2. 904) , and nutritional risk ( HR = 2. 186, 95% CI:1. 517-3. 150) were independent risk factors for recurrence in HCC patients, and vascular invasion ( HR = 1. 823, 95% CI: 1. 265-2. 627) and nutritional risk ( HR = 2. 068, 95% CI: 1. 431-2. 990) were independent risk factors for death in HCC patients. Conclusion According to the nutritional screening results based on the NRS-2002 score, there is a high proportion of HCC patients with nutritional risk before surgery, which is associated with postoperative recurrence and death.
- carcinoma, hepatocellular /
- nutritional risk assessment scale /
- hepatectomy /
- prognosis

HTML全文

参考文献(20)

[1] AKINYEMIJU T, ABERA S, AHMED M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to2015 at the global, regional, and national level:Results from the global burden of disease study 2015[J]. JAMA Oncol, 2017, 3 (12) :1683-1691.

[2] TORZILLI G, BELGHITI J, KOKUDO N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers[J]. Ann Surg, 2013, 257 (5) :929-937.

[3] LIU J, GAO CD, ZHANG LX. Influence of neutrophil-lymphocyte ratio on prognosis of liver cancer:A meta-analysis[J].J Clin Hepatol, 2017, 33 (7) :1305-1309. (in Chinese) 刘健, 高驰丹, 张立鑫, 等.中性粒细胞与淋巴细胞比值对肝癌预后影响的Meta分析[J].临床肝胆病杂志, 2017, 33 (7) :1305-1309.

[4] CHEN K, ZHAN MX, HU BS, et al. Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma[J]. Oncol Lett, 2018, 15 (1) :315-323.

[5] LI YF, NIE RC, WU T, et al. Prognostic value of the nutritional risk screening 2002 scale in metastatic gastric cancer:A large-scale cohort study[J]. J Cancer, 2019, 10 (1) :112-119.

[6] IILLA P, MARCELA T, JANA S. Screening of malnutrition risk versus indicators of nutritional status and systemic inflammatory response in newly diagnosed lung cancer patients[J]. Klin Onkol, 2014, 27 (4) :261-268.

[7] WANG J, YU BQ, YE YJ, et al. Predictive value of nutritional risk screening 2002 and prognostic nutritional index for esophageal cancer patients undergoing definitive radiochemotherapy[J]. Nutr Cancer, 2018, 70 (6) :879-885.

[8] CHUA DW, XIN KY, XIN LY, et al. Pre-operative predictors of early recurrence/mortality including the role of inflammatory indices in patients undergoing partial hepatectomy for spontaneously ruptured hepatocellular carcinoma[J]. J Surg Oncol, 2018, 118 (8) :1227-1236.

[9] Liver Surgery Group, Surgical Society of Chinese Medical Association. Expert consensus on selection of surgical treatments for hepatocellular carcinoma (2016 3rd edition) [J]. Chin J Dig Surg, 2017, 16 (2) :113-115. (in Chinese) 中华医学会外科学分会肝脏外科学组.肝细胞癌外科治疗方法的选择专家共识 (2016年第3次修订) [J].中华消化外科杂志, 2017, 16 (2) :113-115.

[10] KONDRUP J, RASMUSSE HH, HAMBERG O, et al. Nutritional risk screening (NRS 2002) :A new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22 (3) :321-336.

[11] LIU AX, WANG HQ, BO WT, et al. Clinical efficacy and prognostic factors analysis of hepatectomy for hepatocellular carcinoma[J]. Chin J Dig Surg, 2019, 18 (4) :368-374. (in Chinese) 刘爱祥, 王海清, 薄文滔, 等.肝细胞癌肝切除术的临床疗效及预后因素分析[J].中华消化外科杂志, 2019, 18 (4) :368-374.

[12] OMATE M, LESMANA LA, TATEISHI R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma[J]. Hepatol Int, 2010, 4 (2) :439-474.

[13] ZHANG TT, ZHAO XQ, LIU Z, et al. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy:A retrospective study of 601 Chinese patients[J].Clin Transl Oncol, 2016, 18 (8) :831-840.

[14] ARENDS JJ. ESPEN guidelines on nutrition in cancer patients[J]. Clin Nutr, 2017, 36 (1) :11-48.

[15] WOO SM, PARK JW, LEE WJ, et al. Clinical and virological responses to clevudine therapy of hepatocelluar carcinoma patients with chronic hepatitis B[J]. Gut Liver, 2011, 5 (1) :82-87.

[16] HAN B, DING YT, BIAN XJ, et al. Clinical value of preoperative nutritional support therapy in the hepatectomy of patients with nutritional risk:A prospective study[J]. Chin J Dig Surg, 2017, 16 (12) :1183-1190. (in Chinese) 韩冰, 丁义涛, 卞晓洁, 等.术前营养支持治疗在有营养风险患者肝切除术中临床价值的前瞻性研究[J].中华消化外科杂志, 2017, 16 (12) :1183-1190.

[17] SCHUTTE K, TIPPELT B, SCHULZ C, et al. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC) [J]. Clin Nutr, 2014, 34 (6) :1122-1127.

[18] ALESSIO M, SHEEVA J, VALENTINA M. The challenges of nutritional assessment in cirrhosis[J]. Curr Nutr Rep, 2017, 6 (3) :274-280.

[19] TANDON P, RAMAN M, MOURTZAKIS M, et al. A practical approach to nutritional screening and assessment in cirrhosis[J]. Hepatology, 2016, 65 (3) :1044-1057.

[20] KIM JH, SINN DH, GWAK GY, et al. Insulin resistance assessment is useful in risk stratification of hepatocellular carcinoma in chronic hepatitis B patients[J]. J Gastroenterol Hepatol, 2017, 32 (5) :1100-1106.

施引文献

期刊类型引用(11)

1.	谢亚明，梁磊，肖遵强，刘军伟，张成武，黄东胜. Naples预后评分对肝细胞癌患者肝切除术后预后的影响. 中华肝胆外科杂志. 2024(05): 341-346 . 百度学术
2.	何银连，陈宏明，罗桂荣，李日著，李燕飞，黄琳. 高龄低体质指数食管癌病人围术期营养管理的研究进展. 全科护理. 2024(20): 3829-3831 . 百度学术
3.	杨平，郭杨. 术前营养状态对肝细胞癌肝切除术结局的影响进展. 中国临床研究. 2023(02): 218-222 . 百度学术
4.	张秋青，吴晓燕. 1例食管癌终末期患者的安宁疗护实践. 当代护士(上旬刊). 2023(12): 154-157 . 百度学术
5.	王粉芝，权维维，魏莹，赵宗辽. 基于营养评估的综合营养支持对肝癌化疗栓塞术后患者免疫功能、营养状态及生命质量的影响. 保健医学研究与实践. 2023(S2): 150-153 . 百度学术
6.	张宇洁，何兰英. 营养风险筛查联合疼痛评估在食管癌手术患者中的应用. 当代护士(上旬刊). 2022(02): 99-102 . 百度学术
7.	杨许威，刘真义，王秋雁. 整蛋白型肠内营养对老年肝硬化患者营养指标、NRS2002评分、肝功能及并发症的影响. 中国肝脏病杂志(电子版). 2021(01): 46-51 . 百度学术
8.	张华安，周晓芳，蒋易君，张淏嘉. NRS-2002联合炎症反应标志物预测恶性梗阻性黄疸患者预后的Nomogram模型构建. 山东医药. 2021(16): 35-40 . 百度学术
9.	黄桂荣，吴德平，陈方鹏，韩山山. NRS-2002和CONUT评分与中晚期肝细胞癌患者预后分析及Nomogram模型构建. 肝癌电子杂志. 2021(02): 62-68 . 百度学术
10.	谢元康，李文龙，刘津平，温超. NRS2002与血清前白蛋白在肝胆管结石患者预后评估中的应用价值. 中外医疗. 2021(26): 5-8 . 百度学术
11.	王朝，韩山山，陈述，丁胜义，冯志强. 结合营养风险筛查2002构建预测肝细胞癌患者复发的Nomogram模型. 肝癌电子杂志. 2020(03): 22-29 . 百度学术